Fatty Liver Disease: Experts Call for Shifting Perceptions and Improving Diagnosis
Translated & summarized from TheMarker by baba
Experts at a conference called for a change in how fatty liver disease is perceived, noting its widespread nature and links to heart disease. While most cases are not severe, a significant minority can lead to cirrhosis. Challenges include the disease's asymptomatic early stages and underreporting, leading to calls for better diagnostic tools and physician training. New medications show promise for treating both cardiovascular issues and fatty liver, with early detection being key to reversing the condition.
The story in 6 lines · by baba
- Experts at a conference called for a change in perception regarding fatty liver disease, a condition affecting 1.7 billion people worldwide.
- Fatty liver disease is often asymptomatic in its early stages, leading to underreporting and delayed diagnosis.
- New medications, initially for diabetes and obesity, show promise in reducing cardiovascular risks and treating fatty liver.
- Early detection and intervention are crucial for reversing fatty liver disease and preventing severe complications like cirrhosis.
- There is a strong link between fatty liver disease and increased risk of heart attacks, strokes, and other cardiovascular events.
- Healthcare systems are urged to implement better diagnostic tools and training for family doctors to identify at-risk patients.
A panel discussion at TheMarker's Obesity Conference highlighted the urgent need to change public and medical perceptions of fatty liver disease, a condition affecting an estimated 1.7 billion people globally. Despite its prevalence and connection to cardiovascular diseases, many remain unaware of its dangers. Professor Ziv Ben-Ari, Director of the Center of Excellence for Liver Medicine at Assuta Medical Centers, noted that while most cases do not progress to severe stages like cirrhosis, a small percentage do, increasing mortality risk. The primary goal, she stated, is to non-invasively identify high-risk individuals for personalized treatment.
One of the main challenges is the disease's asymptomatic nature in early stages and underreporting within healthcare systems. Dr. Lydia Miller, a family medicine specialist, pointed out a gap between available diagnostic tools for family doctors and their actual use, citing time constraints and difficulty in identifying at-risk patients. She advocated for computational tools, like the FIB-4 index, to be integrated into electronic health records to automatically flag high-risk individuals and for improved training and accessibility to advanced tests like FibroScan in the community.
Dr. Naomi Sigal, Head of Medical Technologies at Maccabi Healthcare Services, described ongoing efforts to improve diagnosis and prevention, including computerized registries that alert family doctors to at-risk patients and an app promoting healthy lifestyles. Maccabi is also collaborating with local authorities to map at-risk populations and implement community-based health initiatives. Future developments include automated patient screening and digital platforms focused on longevity and preventative care.
Dr. Orly Sana Arbiv, Director of Gastroenterology and Liver Diseases at Clalit Health Services, emphasized the significant shift in understanding the disease, noting that fatty liver complications are a major reason for liver transplant candidates in Israel. She stressed that the disease is reversible in its early stages, making early detection crucial.
Professor Saar Manna, Director of Invasive Cardiology at Shamir Medical Center, detailed the strong link between fatty liver disease and heart conditions, explaining that inflammation from excess fat tissue contributes to accelerated atherosclerosis, heart attacks, and strokes. He highlighted new drug classes, initially developed for diabetes and obesity, that have shown a significant reduction in cardiovascular event risk and are now being studied for their impact on fatty liver disease, urging cardiologists to support family doctors in identifying and managing the condition.